Objectives: Terlipressin is used in esophageal variceal bleed (EVB) along with Endoscopic Band Ligation (EBL) for 3days (UC). Due to its high cost, it was stopped <3days (SC) who could not afford & were stable after achieving hemostasis with EBL. We retrospectively assessed the efficacy of SC Vs UC of Terlipressin for control of EVB and length of stay. Conclusion: The APRI of 1.5 in combination with HA 300 ng/ml as cut-off points to predict patients with moderate to severe fibrosis (stages 2-4) is an easy and accurate method.